Cargando…

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD), the most common histotype of lung cancer, may have variable prognosis due to molecular variations. The research strived to establish a prognostic model based on malignancy-related risk score (MRRS) in LUAD. METHODS: We applied the single-cell RNA sequencing (s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Mengxi, Wu, Zhenyu, Yan, Jun, Zeng, Jie, Kuang, Jun, Zhong, Chenghua, Zhu, Xiaojia, Mo, Yijun, Guo, Quanwei, Li, Dongfang, Tan, Jianfeng, Zhang, Tao, Zhang, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327591/ https://www.ncbi.nlm.nih.gov/pubmed/37427142 http://dx.doi.org/10.3389/fonc.2023.1198746

Ejemplares similares

Enhancing vigilance for cerebral air embolism after pneumonectomy: a case report
por: Mo, Yijun, et al.
Publicado: (2021)

Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
por: Zhu, Leqing, et al.
Publicado: (2023)

microRNA-130b-3p Contained in MSC-Derived EVs Promotes Lung Cancer Progression by Regulating the FOXO3/NFE2L2/TXNRD1 Axis
por: Guo, Quanwei, et al.
Publicado: (2020)

Biomimetic lung-on-a-chip to model virus infection and drug evaluation
por: Tan, Jianfeng, et al.
Publicado: (2023)

A prognostic signature model for unveiling tumor progression in lung adenocarcinoma
por: Li, Zijian, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

Case Report: Long-term remission of malignant pleural and peritoneal effusion in a case of advanced lung adenocarcinoma treated with combined crizotinib and anlotinib therapy
por: Tian, Jin, et al.
Publicado: (2023)

Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma
por: Liu, Yunxun, et al.
Publicado: (2023)

SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report
por: Ma, Lin, et al.
Publicado: (2022)

Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022)

Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma
por: Zhou, Jian-Guo, et al.
Publicado: (2019)

Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma
por: Zhang, Jiawei, et al.
Publicado: (2022)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
por: Bian, Chengyu, et al.
Publicado: (2022)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma
por: Liang, Jun-Ze, et al.
Publicado: (2021)

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
por: Zhang, Minghui, et al.
Publicado: (2019)

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion
por: Li, Jinyou, et al.
Publicado: (2023)

A signature-based classification of lung adenocarcinoma that stratifies tumor immunity
por: Zhang, Xun, et al.
Publicado: (2023)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
por: Yang, Jing, et al.
Publicado: (2022)

Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
por: Li, Hui, et al.
Publicado: (2023)

The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA sequence
por: Ye, Chen, et al.
Publicado: (2023)

Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram
por: Wu, Aihua, et al.
Publicado: (2021)

Malignant priapismus induced by adenocarcinoma of the prostate
por: Sibarani, Jupiter, et al.
Publicado: (2019)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

The Role of Preoperative Computed Tomography Radiomics in Distinguishing Benign and Malignant Tumors of the Parotid Gland
por: Xu, Yuyun, et al.
Publicado: (2021)

Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma
por: Chen, Jun, et al.
Publicado: (2022)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma
por: Hong, Duo, et al.
Publicado: (2020)

Construction of a Novel Ferroptosis-Related Gene Signature for Predicting Survival of Patients With Lung Adenocarcinoma
por: Song, Xiaojie, et al.
Publicado: (2022)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer
por: Wu, Meijuan, et al.
Publicado: (2021)

A Novel Secreted Protein-Related Gene Signature Predicts Overall Survival and Is Associated With Tumor Immunity in Patients With Lung Adenocarcinoma
por: Chen, Shuaijun, et al.
Publicado: (2022)

Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
por: Qu, Xueling, et al.
Publicado: (2019)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mg5466n57cgrbe5s4mjuvpsscj